A
MDGL icon

AlphaQuest’s Madrigal Pharmaceuticals MDGL Stock Holding History

AlphaQuest’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-420
Closed -$245K – 1207
2025
Q4 		$245K Buy
420
+368
+708% +$188K 0.01% 1344
2025
Q3 		$23.9K Sell
52
-30
-37% -$11.2K ﹤0.01% 2068
2025
Q2 		$24.8K Buy
82
+66
+413% +$19.7K ﹤0.01% 1758
2025
Q1 		$5.3K Buy
+16
New +$5.26K ﹤0.01% 1857
2024
Q4 		– Sell
-581
Closed -$123K – 1901
2024
Q3 		$123K Buy
581
+368
+173% +$94.1K 0.01% 1237
2024
Q2 		$59.7K Buy
213
+209
+5,225% +$49.8K 0.01% 1047
2024
Q1 		$1.07K Buy
+4
New +$942 ﹤0.01% 1385

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AlphaQuest's MDGL Position: Q1 2026 in Review

AlphaQuest sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2026, closing a stake of 420 shares — an estimated $245K sold.

AlphaQuest first reported a position in MDGL in Q1 2024 and held it in 7 quarters. The position peaked at $245K in Q4 2025. 380 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • AlphaQuest reported no remaining Madrigal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 420 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $245K.
  • AlphaQuest first reported a position in Madrigal Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • AlphaQuest's Madrigal Pharmaceuticals position peaked at $245K in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.